Cardiovascular toxicity of valdecoxib

被引：44
|
作者：
Ray, WA [1 ]
Griffin, MR [1 ]
Stein, CM [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 26期
关键词：
D O I：
10.1056/NEJMc045711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2767 / 2767
页数：1
相关论文
共 50 条
  • [1] Parecoxib, valdecoxib, and cardiovascular risk
    Furberg, CD
    Psaty, BM
    FitzGerald, GA
    CIRCULATION, 2005, 111 (03) : 249 - 249
  • [2] Valdecoxib meta-analysis finds increased cardiovascular risk
    不详
    FORMULARY, 2004, 39 (12) : 586 - 586
  • [3] Valdecoxib
    Douglas Ormrod
    Ken Wellington
    Antona J. Wagstaff
    Drugs, 2002, 62 : 2059 - 2071
  • [4] Valdecoxib
    Ormrod, D
    Wellington, K
    Wagstaff, AJ
    DRUGS, 2002, 62 (14) : 2059 - 2071
  • [5] CARDIOVASCULAR TOXICITY
    GOLDBERG, LI
    WENGER, NK
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1965, 123 (A1) : 333 - &
  • [6] Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs
    Capone, Marta L.
    Tacconelli, Stefania
    Di Francesco, Luigia
    Petrelli, Maria
    Patrignani, Paola
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (01) : 29 - 42
  • [7] Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis
    Aldington, Sarah
    Shirtcliffe, Philippa
    Weatherall, Mark
    Beasley, Richard
    NEW ZEALAND MEDICAL JOURNAL, 2005, 118 (1226) : 48 - 56
  • [8] A pseudopolymorph of valdecoxib
    Yathirajan, HS
    Narasegowda, RS
    Nagaraja, P
    Bolte, M
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O179 - O181
  • [9] Sintilimab and Cardiovascular Toxicity
    Peng, Linfeng
    Yang, Dandan
    Weng, Cuilian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (15):
  • [10] THE CARDIOVASCULAR TOXICITY OF ANTIDEPRESSANTS
    WARRINGTON, SJ
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1988, 3 : 63 - 70
12345